Expertise in
1
conditions

Frederic Heluwaert

Annecy, FR 
Expertise in
1
conditions
Annecy, FR 
OverviewLocationsClinical Research

Overview

Frederic Heluwaert practices in Annecy, France. Mr. Heluwaert is highly rated in 1 condition, according to our data. His top areas of expertise are Helicobacter Pylori Infection, Hepatitis, Hepatitis C, and Viral Gastroenteritis.

His clinical research consists of co-authoring 18 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Annecy, 74000, France
Other Locations
Epagny, France
Pringy, 74370, France
1, Avenue De L'Hôpital, Metz, 74370, France
France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Impact of Anti-cytomegalovirus (Valganciclovir) Treatment in the Management of Relapsing Ulcerative Colitis (UC) Requiring Vedolizumab Therapy: a Randomized Clinical Trial Comparing a Strategy With or Without Antiviral Therapy.
Impact of Anti-cytomegalovirus (Valganciclovir) Treatment in the Management of Relapsing Ulcerative Colitis (UC) Requiring Vedolizumab Therapy: a Randomized Clinical Trial Comparing a Strategy With or Without Antiviral Therapy.
Enrollment Status: Terminated
Publish Date: April 10, 2024
Intervention Type: Drug
Study Drug: Valganciclovir
Study Phase: Phase 3
Follow-up of HBsAg Inactive Carriers Study
Follow-up of HBsAg Inactive Carriers Study
Enrollment Status: Completed
Publish Date: April 06, 2022
Intervention Type: Other
Study Phase: Not Applicable
Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants
Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants
Enrollment Status: Completed
Publish Date: October 06, 2021
Intervention Type: Other
View 2 Less Clinical Trials

18 Total Publications

PErsistence and Safety of Subcutaneous Infliximab 1 Year After Switch From Intravenous Route in IBD Patients in REMission.
PErsistence and Safety of Subcutaneous Infliximab 1 Year After Switch From Intravenous Route in IBD Patients in REMission.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 26, 2024

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Heluwaert's expertise for a condition
ConditionClose
      View All 10 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile